Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial

Authors: Emily K. Yeung, Thomas W. Ferguson, Navdeep Tangri, Muthiah Vaduganathan, Clare Gabrielle Arnott, Min Jun, Sradha S. Kotwal, Meg Jardine, Vlado Perkovic, Hiddo Jan L. Heerspink, Brendon Lange Neuen

Published: 2024-10-28

DOI: 10.1681/asn.2024k6fn2ax5

Keywords: No keywords found.

Abstract:
No abstract found.

Source: